Last edition
News about "Domestic Momentum Fails Pharma "
Domestic Momentum Fails to Offset US Pressure on Pharma Margins: Report
India’s pharmaceutical sector is expected to report steady domestic growth in Q4 FY26, but overall earnings are likely to come under pressure due to continued weakness in the US market, according to a report by Nuvama Institutional Equities.
Domestic Momentum Fails Pharma | 10/04/2026 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members